NCT05508737 2025-07-11Pembrolizumab and Trifluridine/Tipiracil With Previously Treated Advanced Gastric CancerYonsei UniversityPhase 1/2 Active not recruiting75 enrolled
NCT05201352 2025-05-30TASKINCentre Georges Francois LeclercPhase 1/2 Active not recruiting160 enrolled
NCT03368963 2025-01-07TAS102 in Combination With NAL-IRI in Advanced GI CancersEmory UniversityPhase 1/2 Active not recruiting64 enrolled